A patient’s access to a potentially life-changing therapy should not depend on their postal code. Today, patients in Ontario and B.C. have pathways to receive the first gene therapy approved in Canada for hemophilia B. But patients in other provinces face uncertainty.
The cost and support needed to pursue experiential learning opportunities can be major barriers, but the federal government can help students by funding scholarship programs that empower young global leaders.